Drug intelligence / Profile preview

αIR3

Development stage
Discontinued
Lead developer
Siemens
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

αIR3 is a mouse monoclonal antibody (IgG1) that specifically binds to and neutralizes the human insulin-like growth factor-1 receptor (IGF-1R). It functions by blocking the binding of IGF-1 and IGF-2 to the receptor, thereby inhibiting downstream signaling pathways such as PI3K/Akt and MAPK. While primarily used as a research tool to study cancer cell proliferation, apoptosis, and cell cycle arrest in various malignancies (including lung, breast, and hepatocellular carcinoma), it has also been observed to exhibit paradoxical IGF-1 mimetic activity and can induce receptor internalization and down-regulation. It is widely available as a laboratory reagent but has not transitioned into clinical development as a therapeutic agent.

Other names
anti-IGF-1R antibody clone αIR3clone αIR3
02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)INSR (Insulin receptor)

Beyond the preview

Go deeper on αIR3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on αIR3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call